Tenaya Therapeutics

Tenaya Therapeutics develops gene therapies and precision medicines for heart disease, targeting conditions like hypertrophic cardiomyopathy.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series C
Initial Investment Year
2020
Tenaya Tx Hover Image